ENDP Endo International Plc

Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.

$6.20  -0.07 (-1.12%)
As of 04/09/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  Ireland
IPO date:  02/11/2013
Outstanding shares:  230,500,639
Average volume:  3,134,758
Market cap:   $1,429,103,962
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G30401106
ISIN:        IE00BJ3V9050
Sedol:      BJ3V905
Valuation   (See tab for details)
PE ratio:   7.77
PB ratio:   -2.38
PS ratio:   0.49
Return on equity:   -28.39%
Net income %:   6.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy